Owlet (OWLT) Resumen de Acciones
Owlet, Inc. ofrece soluciones digitales para padres en Estados Unidos, Reino Unido e internacionalmente. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 4/6 |
| Crecimiento futuro | 1/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 6/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
OWLT Community Fair Values
Create NarrativeSee what 19 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Owlet, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$4.54 |
| Máximo en las últimas 52 semanas | US$16.94 |
| Mínimo de 52 semanas | US$4.19 |
| Beta | 1.9 |
| Cambio en 1 mes | -25.70% |
| Variación en 3 meses | -9.20% |
| Cambio de 1 año | -39.22% |
| Variación en 3 años | 20.11% |
| Variación en 5 años | -94.23% |
| Variación desde la OPV | -96.66% |
Noticias y actualizaciones recientes
Seeking Alpha • Sep 04
Owlet: The Business Is Growing, But The Stock Isn't
Summary Owlet remains a buy despite flat stock performance, supported by strong Q2 results and ongoing business evolution. Q2 revenue hit a record $33.9M (up 29.9% YoY), with gross margin rebounding to 54% and subscription growth driving margin expansion. Management maintained 2026 guidance, forecasting $120M revenue (13.5% growth) and $8M EBITDA, with international and subscription segments as key growth drivers. OWLT's FDA approval and Amazon enforcement could reduce competition, while a direct subscription model and telehealth expansion offer future margin and growth catalysts. Read the full article on Seeking Alpha
Actualización de narrativa • Jul 24
OWLT: Customer Adoption And Subscriptions Will Drive Future Upside Potential
Owlet's updated analyst price target shifts from $20 to $15 as analysts factor in revised growth expectations, slightly adjusted discount rates, and a lower future P/E multiple, while still highlighting the potential for upside from increased customer adoption and subscriptions. What’s in the News for Owlet Owlet, Inc.Recent updates
Seeking Alpha • Sep 04
Owlet: The Business Is Growing, But The Stock Isn't
Summary Owlet remains a buy despite flat stock performance, supported by strong Q2 results and ongoing business evolution. Q2 revenue hit a record $33.9M (up 29.9% YoY), with gross margin rebounding to 54% and subscription growth driving margin expansion. Management maintained 2026 guidance, forecasting $120M revenue (13.5% growth) and $8M EBITDA, with international and subscription segments as key growth drivers. OWLT's FDA approval and Amazon enforcement could reduce competition, while a direct subscription model and telehealth expansion offer future margin and growth catalysts. Read the full article on Seeking AlphaActualización de narrativa • Jul 24
OWLT: Customer Adoption And Subscriptions Will Drive Future Upside Potential
Owlet's updated analyst price target shifts from $20 to $15 as analysts factor in revised growth expectations, slightly adjusted discount rates, and a lower future P/E multiple, while still highlighting the potential for upside from increased customer adoption and subscriptions. What’s in the News for Owlet Owlet, Inc.
Actualización de narrativa • Jul 10
OWLT: Guidance Reset And Subscriptions Are Expected To Drive Upside
Analysts have lowered their price target on Owlet stock from $13 to $10, reflecting a reset in expectations while still highlighting what they see as an underappreciated brand with potential for upside as customer adoption and subscription features develop. What’s in the News for Owlet Owlet, Inc.
Actualización de narrativa • Jun 26
OWLT: Guidance Reset And Adoption Initiatives Will Support Future Execution
Analysts have trimmed their fair value estimate for Owlet from $17.00 to $13.00, reflecting updated assumptions on growth, profitability, and P/E, while still pointing to potential upside supported by views that the recent guidance reset and improving hardware and subscription features could attract more customers over time. What's in the News for Owlet Owlet launched Dream Sight and Dream Duo 3 across Australia and New Zealand, bringing its full lineup of baby monitoring products, including Dream Sock, to those markets for the first time.Actualización de narrativa • Jun 04
OWLT: Softer Q1 Guide Seen Preceding Stronger 2026 Second Half
Narrative Update The analyst price target for Owlet has been reduced from $20 to $15, with analysts pointing to softer Q1 guidance, while also noting 2026 expectations that suggest a more robust back half of that year. What's in the News Owlet launched Dream Sight and Dream Duo 3 across Australia and New Zealand, expanding its full baby monitoring product lineup in those markets, including Dream Sock, Dream Sight, and Dream Duo 3.Actualización de narrativa • May 11
OWLT: Softer Q1 Outlook Seen Setting Up Stronger 2026 Finish
Analysts have trimmed their price target on Owlet stock to $15 from $20, citing Q1 guidance that came in below expectations, while highlighting that 2026 guidance still lines up with prior views and points to a potentially stronger second half of that year. Analyst Commentary Bearish analysts are signaling a more cautious stance on Owlet after recent guidance, using the reduced price target as a way to reset expectations while still acknowledging longer term potential.Actualización de narrativa • Apr 20
OWLT: Softer Q1 Outlook Expected To Set Up Stronger Second Half 2026
Analysts have lowered their price target on Owlet to $15 from $20, citing slightly softer Q1 guidance versus expectations. They also note that current management guidance indicates the second half of 2026 could be more robust.Actualización de narrativa • Apr 05
OWLT: Guidance And Partnerships Are Expected To Support A Stronger Second Half 2026
Analysts have revised Owlet's price target to $15, down from $19, reflecting mixed near term guidance and updated models that still indicate the possibility of stronger performance in the longer term. Analyst Commentary Recent research updates on Owlet point to a more cautious tone, even as some longer term expectations remain in place.Actualización de narrativa • Mar 22
OWLT: Updated Modeling And Healthcare Partnerships Will Support Stronger Second Half 2026
Analysts have updated their view on Owlet, trimming the consolidated price target to $15 as they factor in softer Q1 guidance, a higher assumed P/E multiple and lower projected revenue growth and profit margins, while still highlighting expectations for a stronger second half of 2026. Analyst Commentary Recent research highlights a more measured tone around Owlet, with some price targets recalibrated as analysts balance solid past execution with softer near term guidance and updated valuation assumptions.Actualización de narrativa • Mar 08
OWLT: Updated Modeling And New Healthcare Partnerships Will Support Future Upside Potential
Analysts have adjusted their outlook on Owlet, trimming the price target from $14 to $13 as they factor in updated expectations for growth, profitability, and future P/E assumptions that are informed by recent research highlighting mixed near term guidance alongside longer term projections that are described as steady. Analyst Commentary Recent Street research reflects a mixed but increasingly cautious tone around Owlet, with some bearish analysts trimming price targets as they reassess growth visibility and execution risk against current valuation.Actualización de narrativa • Feb 22
OWLT: Updated Modeling And FDA Pathways Will Support Future Upside Potential
Analysts have lifted their price target on Owlet to $19 from $15, citing updated modeling assumptions following a transfer of coverage. Analyst Commentary Recent research points to a reset in expectations around Owlet, with updated modeling used to support a US$19 price target.Actualización de narrativa • Feb 07
OWLT: Additional Liquidity And Partnerships Will Extend Funding Runway
Analysts have lifted their price target on Owlet to US$20 from US$15, citing updated models that factor in recent Street research highlighting a refreshed coverage framework and additional liquidity that supports the company’s plans. Analyst Commentary Bullish analysts are pointing to recent price target revisions as a sign of growing confidence in Owlet’s ability to execute on its plans, especially as fresh research coverage and additional liquidity are incorporated into updated models.Artículo de análisis • Feb 05
Some Owlet, Inc. (NYSE:OWLT) Shareholders Look For Exit As Shares Take 31% Pounding
Owlet, Inc. ( NYSE:OWLT ) shares have retraced a considerable 31% in the last month, reversing a fair amount of their...Actualización de narrativa • Jan 24
OWLT: Liquidity And New Coverage Models Will Support Future Execution
Narrative Update: Owlet Analyst Price Target Shift Analysts have lifted their price target on Owlet from US$16 to US$17, reflecting updated models that factor in recent target increases on the Street and comfort with assumptions around fair value, discount rate, and a higher future P/E multiple. Analyst Commentary Recent Street research has tilted constructive on Owlet, with bullish analysts lifting price targets and updating their models following new company information and a transfer of coverage.Actualización de narrativa • Jan 09
OWLT: Liquidity And Regulatory Progress Will Support Execution While Risks Remain
Analysts have lifted their price target on Owlet to US$16.00 from US$14.88, citing refreshed models that factor in recent price target increases from firms updating coverage and highlighting added liquidity to support R&D into 2026. Analyst Commentary Recent Street research has trended constructive on Owlet, with higher price targets reflecting refreshed coverage models and a focus on liquidity and execution into 2026.Actualización de narrativa • Dec 15
OWLT: FDA Focus And Global Expansion Will Shape Balanced Risk Profile
Analysts have raised their fair value estimate for Owlet from $11.00 to $14.00 per share, citing stronger projected revenue growth, improved liquidity from a recent stock offering, and an FDA highlighted competitive moat that supports a higher long term price target. Analyst Commentary Recent research commentary has underscored a more constructive outlook on Owlet, with price targets moving higher following what was described as a solid quarter and improved balance sheet flexibility.Artículo de análisis • Dec 05
There's Reason For Concern Over Owlet, Inc.'s (NYSE:OWLT) Massive 67% Price Jump
Owlet, Inc. ( NYSE:OWLT ) shares have continued their recent momentum with a 67% gain in the last month alone. The...Actualización de narrativa • Dec 01
OWLT: Regulatory Momentum And FDA Approval Will Drive Market Leadership Forward
Analysts have increased their price target for Owlet to $15.50 from $12.00, citing a solid quarter, improved liquidity, and the company's status as the only FDA-approved over-the-counter infant monitoring device as key drivers for their more favorable outlook. Analyst Commentary Recent analyst perspectives on Owlet reflect a mixed but largely positive sentiment following the company's most recent financial results and regulatory developments.Actualización de narrativa • Nov 17
OWLT: Regulatory Approvals And Increased Liquidity Will Support Long-Term Market Leadership
Analysts have raised their price target for Owlet from $13.20 to $14.83. They cite stronger revenue growth, improved profitability, and increased liquidity following the company's solid recent quarter.Artículo de análisis • Oct 07
Further Upside For Owlet, Inc. (NYSE:OWLT) Shares Could Introduce Price Risks After 31% Bounce
Owlet, Inc. ( NYSE:OWLT ) shares have had a really impressive month, gaining 31% after a shaky period beforehand. The...Actualización de narrativa • Aug 09
Telehealth Partnerships And AI Insights Will Broaden Digital Health Markets
Driven by strong consumer demand for its FDA-cleared Dream Sock and a unique competitive position, analysts have raised Owlet’s price target from $12.30 to $13.20. Analyst Commentary The $300 Dream Sock is currently a best-selling smart baby monitor on Amazon, demonstrating strong consumer traction.Artículo de análisis • Jun 14
Investors Still Aren't Entirely Convinced By Owlet, Inc.'s (NYSE:OWLT) Revenues Despite 34% Price Jump
Owlet, Inc. ( NYSE:OWLT ) shares have continued their recent momentum with a 34% gain in the last month alone. The last...
Nueva narrativa • Apr 10
Dream Sock, BabySat, And Company360 Will Expand Global Healthcare Access
Owlet's FDA and CE approvals pave the way for global market expansion, boosting international revenue potential.Rentabilidad de los accionistas
| OWLT | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | -6.6% | 0.7% | -1.1% |
| 1Y | -39.2% | -15.8% | 11.7% |
Rentabilidad vs. Industria: Los resultados de OWLT fueron inferiores a los de la industria US Medical Equipment, que obtuvo un rendimiento del -15.8% el año pasado.
Rentabilidad vs. Mercado: OWLT obtuvo unos resultados inferiores a los del mercado US, que fueron del 11.7% el año pasado.
Volatilidad de los precios
| OWLT volatility | |
|---|---|
| OWLT Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: OWLT no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de OWLT (9%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2012 | 111 | Kurt Workman | www.owletcare.com |
Owlet, Inc. ofrece soluciones digitales para la crianza de los hijos en Estados Unidos, Reino Unido e internacionalmente. La empresa ofrece una plataforma digital de crianza que proporciona datos y perspectivas en tiempo real a los padres. También proporciona monitores de calcetín, como Dream Sock, un monitor portátil de salud infantil equipado con tecnología de pulsioximetría que controla las constantes vitales, como la frecuencia del pulso, la actividad, el nivel de oxígeno y los patrones de sueño; BabySat, destinado a bebés con afecciones, como el virus respiratorio sincitial, neumonía, bronquitis, crup y otros diagnósticos; y Dream Sight, un monitor de audio y vídeo que permite a los padres controlar a su hijo.
Resumen de fundamentos de Owlet, Inc.
| Estadísticas fundamentales de OWLT | |
|---|---|
| Capitalización bursátil | US$135.59m |
| Beneficios(TTM) | -US$13.00m |
| Ingresos (TTM) | US$114.41m |
1.2x
Ratio precio-ventas (PS)-10.2x
Ratio precio-beneficio (PE)¿Está OWLT sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de OWLT | |
|---|---|
| Ingresos | US$114.41m |
| Coste de los ingresos | US$51.97m |
| Beneficio bruto | US$62.44m |
| Otros gastos | US$75.44m |
| Beneficios | -US$13.00m |
Últimos beneficios comunicados
Jun 30, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.44 |
| Margen bruto | 54.57% |
| Margen de beneficio neto | -11.36% |
| Ratio deuda/patrimonio | 46.3% |
¿Cómo se ha desempeñado OWLT a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/09/16 11:27 |
| Precio de las acciones al final del día | 2026/09/16 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Owlet, Inc. está cubierta por 9 analistas. 5 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Allen Lutz | BofA Global Research |
| James Suva | Citigroup Inc |
| Ilya Zubkov | Freedom Broker |